A study investigating pharmacokinetics, safety and efficacy of Sunitinib in patients with advanced renal cell carcinoma.
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 28 Dec 2015 New trial record